20.02
price down icon0.94%   -0.19
 
loading

Zai Lab Limited Adr Aktie (ZLAB) Neueste Nachrichten

pulisher
Nov 19, 2025

Can Zai Lab Limited (1ZLB) stock test all time highsQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com

Nov 19, 2025
pulisher
Nov 09, 2025

Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st

Nov 09, 2025
pulisher
Nov 07, 2025

Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) - simplywall.st

Nov 07, 2025
pulisher
Nov 07, 2025

There is no doubt that Zai Lab Limited ADR (ZLAB) ticks all the boxes. - Setenews

Nov 07, 2025
pulisher
Nov 07, 2025

You might want to take a look at Qualcomm, Inc (QCOM) now - Setenews

Nov 07, 2025
pulisher
Nov 07, 2025

symbol__ Stock Quote Price and Forecast - CNN

Nov 07, 2025
pulisher
Nov 07, 2025

Stocks of Super Group (SGHC) Limited (SGHC) are poised to climb above their peers - setenews.com

Nov 07, 2025
pulisher
Nov 07, 2025

Zai Lab (NASDAQ:ZLAB) Sets New 1-Year Low After Earnings Miss - Defense World

Nov 07, 2025
pulisher
Nov 06, 2025

Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est - GuruFocus

Nov 06, 2025
pulisher
Nov 06, 2025

Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive - simplywall.st

Nov 06, 2025
pulisher
Nov 05, 2025

Why Zai Lab Limited (1ZLB) stock appeals to dividend investors2025 Bull vs Bear & Real-Time Buy Zone Alerts - Fundação Cultural do Pará

Nov 05, 2025
pulisher
Nov 05, 2025

Brokerages Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Price Target at $56.35 - Defense World

Nov 05, 2025
pulisher
Nov 03, 2025

Keeping an Eye on Nine Energy Service Inc (NINE) After Insider Trading Activity - knoxdaily.com

Nov 03, 2025
pulisher
Nov 02, 2025

Zai Lab (NasdaqGM:ZLAB): Evaluating Valuation Following Promising Trial Results and Phase 3 Progress - Sahm

Nov 02, 2025
pulisher
Nov 02, 2025

EBITDA per share of Zai Lab Ltd. Sponsored ADR – GETTEX:1ZL - TradingView

Nov 02, 2025
pulisher
Nov 02, 2025

Did Zai Lab’s (ZLAB) Promising Zoci Trial Results Just Shift Its Investment Narrative? - Sahm

Nov 02, 2025
pulisher
Nov 02, 2025

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Nov 02, 2025
pulisher
Oct 31, 2025

Zai Lab (ZLAB) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Zai Lab Announces Participation in Investor Conferences in November and December 2025 - The Globe and Mail

Oct 31, 2025
pulisher
Oct 30, 2025

Zai Lab Announces Participation in Investor Conferences in September 2025 - Markets Financial Content

Oct 30, 2025
pulisher
Oct 25, 2025

Zai Lab (NASDAQ:ZLAB) Stock Price Down 4.6%Time to Sell? - MarketBeat

Oct 25, 2025
pulisher
Oct 24, 2025

Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer, and Initiation of Global Phase 3 Registrational Study - Business Wire

Oct 24, 2025
pulisher
Oct 23, 2025

Q3 Earnings Estimate for Zai Lab Issued By Leerink Partnrs - MarketBeat

Oct 23, 2025
pulisher
Oct 19, 2025

Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - MSN

Oct 19, 2025
pulisher
Oct 17, 2025

Zai Lab Secures RMB300 Million Debt Facility - The Globe and Mail

Oct 17, 2025
pulisher
Oct 16, 2025

[8-K] Zai Lab Ltd Reports Material Event | ZLAB SEC FilingForm 8-K - Stock Titan

Oct 16, 2025
pulisher
Oct 15, 2025

Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025 - The Globe and Mail

Oct 15, 2025
pulisher
Oct 14, 2025

Zai Lab (NASDAQ:ZLAB) Trading Down 6.2%Here's What Happened - MarketBeat

Oct 14, 2025
pulisher
Oct 13, 2025

Late‑breaking Phase 1 data for Zoci: Zai Lab to present DLL3‑targeted ADC results at AACR Oct 24, 2025 - Stock Titan

Oct 13, 2025
pulisher
Oct 13, 2025

Operating cash flow per share of Zai Lab Ltd. Sponsored ADR – BER:1ZL - TradingView

Oct 13, 2025
pulisher
Oct 13, 2025

Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference - Business Wire

Oct 13, 2025
pulisher
Oct 11, 2025

Trip.com Group LimitedAmerican Depositary Shares (NQ: - FinancialContent

Oct 11, 2025
pulisher
Oct 11, 2025

Is Zai Lab's Valuation Justified as Revenue Growth Lags the Biotech Industry (ZLAB)? - Sahm

Oct 11, 2025
pulisher
Oct 08, 2025

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks - TradingView

Oct 07, 2025
pulisher
Oct 03, 2025

Zai Lab Limited Announces Equity Incentive Grants to Employees - MSN

Oct 03, 2025
pulisher
Sep 30, 2025

Zai Lab (NASDAQ:ZLAB) Shares Gap UpStill a Buy? - MarketBeat

Sep 30, 2025
pulisher
Sep 27, 2025

Zai Lab Limited Depositary Receipt Stock Analysis and ForecastStochastic Oscillator Alerts & High Profit Trading Signals - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Zai Lab (ZLAB) - The Globe and Mail

Sep 27, 2025
pulisher
Sep 26, 2025

How robust is Anheuser Busch Inbev SA Sponsored ADR stock financial position2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com

Sep 26, 2025
pulisher
Sep 22, 2025

Zai Lab Limited Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsZLAB - ACCESS Newswire

Sep 22, 2025
pulisher
Sep 21, 2025

Acadian Asset Management LLC Buys New Shares in Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat

Sep 21, 2025
pulisher
Sep 19, 2025

Levi & Korsinsky Reminds Shareholders of an Investigation into Zai Lab Limited (ZLAB) Regarding Potential Securities Fraud Allegations - ACCESS Newswire

Sep 19, 2025
pulisher
Sep 18, 2025

Lost Money on Zai Lab Limited (ZLAB)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire

Sep 18, 2025
pulisher
Sep 18, 2025

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $56.35 Consensus Price Target from Analysts - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Zai Lab Limited (ZLAB) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Sep 17, 2025
pulisher
Sep 17, 2025

Insider Buying: Zai Lab (NASDAQ:ZLAB) Insider Purchases 10,000 Shares of Stock - MarketBeat

Sep 17, 2025
pulisher
Sep 16, 2025

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $56.35 Average PT from Brokerages - Defense World

Sep 16, 2025
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):